To Determine the Frequency of Biochemical Adverse Effects in Patients on Meglumine Antimoniate Treatment for Cutaneous Leishmaniasis. mfm. 2024;30(9). Accessed April 15, 2026. https://medicalforummonthly.com/index.php/mfm/article/view/3872